Adam Sanford is a strategic commercial leader who helps emerging and established life science organizations accelerate therapeutic and diagnostic innovation. As Senior Director of Business Development at Gannet BioChem, he forges partnerships and collaborations across biotech, pharma, academia, and government, expanding access to Gannet’s PEGylation and activated polymer technologies and solutions.
Adam previously drove global commercial growth at Oligo Factory’s oligonucleotide CDMO business across the full clinical development life cycle. He also held business development roles at Telesis Bio, LGC Biosearch, and CELLINK, supporting teams in genomics, molecular diagnostics, and next-generation automation.
Adam holds an M.Sc. in Chemistry from Northwestern University and a B.A. in Biological Chemistry from Dartmouth College.
